1,4,7-triazacyclononane-n,n',n''-triacetic acid has been researched along with yttrium radioisotopes in 1 studies
| Studies (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Trials (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Recent Studies (post-2010) (1,4,7-triazacyclononane-n,n',n''-triacetic acid) | Studies (yttrium radioisotopes) | Trials (yttrium radioisotopes) | Recent Studies (post-2010) (yttrium radioisotopes) |
|---|---|---|---|---|---|
| 195 | 3 | 161 | 3,407 | 339 | 1,533 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, X; Jacobson, O; Kiesewetter, DO; Liu, Y; Ma, Y; Niu, G; Weiss, ID; Wu, H | 1 |
1 other study(ies) available for 1,4,7-triazacyclononane-n,n',n''-triacetic acid and yttrium radioisotopes
| Article | Year |
|---|---|
Novel "Add-On" Molecule Based on Evans Blue Confers Superior Pharmacokinetics and Transforms Drugs to Theranostic Agents.
Topics: Animals; Cell Line, Tumor; Copper Radioisotopes; Evans Blue; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Integrin alphaVbeta3; Mice; Oligopeptides; Positron-Emission Tomography; Radiochemistry; Radiopharmaceuticals; Tissue Distribution; Yttrium Radioisotopes | 2017 |